FDA - HealthQuill

Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people with type 2 diabetes and chronic kidney disease after the interim results met certain pre-specified” criteria for efficacy.

Novo Nordisk stops testing of Ozempic as kidney trial meets efficacy goals

HQ Team October 11, 2023: Dutch pharmaceutical company, Novo Nordisk, has stopped testing Ozempic to treat the progression of renal impairment in people.

by HealthQuill
October 11, 2023
0 Comments

Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of adverse events, and are not approved by the FDA, the regulator warned.

Drugs Health Pharma

FDA warns patients against use of ketamine for psychiatric disorders

HQ Team October 10, 2023: Compounded ketamine products used to treat psychiatric disorders, are not safe, may put patients at severe risk of.

by HealthQuill
October 10, 2023
0 Comments

Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.

Drugs Health Pharma

Users of diabetic drugs for weight loss at risk of stomach paralysis

HQ Team October 7, 2023: Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction,.

by HealthQuill
October 7, 2023
7 Comments

Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA said it was “unsatisfied” with the status of a recall.

Health Medical Pharma

US drug regulator ‘unsatisfied’ by Philips’s progress on ventilator recall

HQ Team October 6, 2023: Dutch medical device maker, Philips Respironics, agreed to conduct further tests on its faulty ventilators after the USFDA.

by HealthQuill
October 6, 2023
0 Comments

The FDA is planning a pilot program to accelerate the development of drugs and biological products for rare diseases by helping companies gather relevant data and conduct trials.

Drugs Health Pharma

FDA plans project to aid companies in making drugs for rare diseases

HQ Team October 4, 2023: The FDA is planning a pilot program to accelerate the development of drugs and biological products for rare.

by HealthQuill
October 4, 2023
0 Comments

The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12 years of age or above, the regulator announced.

Drugs Health Pharma

Novavax gets FDA nod for updated Covid-19 vaccine for 12 years and above

HQ Team October 4, 2023: The US Food and Drug Administration has cleared Novavax’s updated Covid-19 vaccine for emergency use in adolescents 12.

by HealthQuill
October 4, 2023
0 Comments

Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder (PTSD).

Drugs Health Pharma

Bionomics’ PTSD experimental drug yield positive results in trials

HQ Team September 29, 2023: Bionomics Limited, a clinical-stage biotechnology company announced positive outcomes for its experimental drug to treat post-traumatic stress disorder.